PRA Health Sciences Email Format
Biotechnology Research
・
10,001-25,000 employees
・
Dublin, Ireland
PRA Health Sciences is a global contract research organization that provides clinical development, consulting, and commercialization services to pharmaceutical and biotechnology companies worldwide.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
firstlast@prahs.com
Company Overview
Industry
Biotechnology Research
Founded
1990
Headquarters
Dublin, Ireland
Revenue
$2.5B-$5B
FUNDING Stage
Public
Website
Key Executives
Barry Balfe (Chief Executive Officer), Nigel Clerkin (Chief Financial Officer), Tom O'Leary (Chief Information Officer)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of PRA Health Sciences?
PRA Health Sciences uses the firstlast format, so Jane Smith would be janesmith@prahs.com.
What types of clinical development services does PRA Health Sciences offer?
PRA Health Sciences provides outsourced clinical development services spanning Phase I through Phase IV, including early development, clinical trial management, data management, statistical analysis, medical writing, pharmacovigilance, and bioanalytical laboratory services for pharmaceutical and biotechnology clients.
Where does PRA Health Sciences operate globally?
PRA Health Sciences operates across more than 90 countries, with offices spanning North America, Europe, Asia, Latin America, Africa, and Australia, giving the company broad geographic reach for running multinational clinical trials.
How can I find and verify a PRA Health Sciences contact at prahs.com?
Since PRA Health Sciences uses the firstlast format at prahs.com, you can build a likely address and verify it using a tool like Clay, which can confirm whether an email is deliverable before you reach out to a specific contact.
Founded in 1976, how did PRA Health Sciences grow into a major contract research organization?
PRA Health Sciences started as the Anti-Inflammatory Drug Study Group in Charlottesville, Virginia in 1976, expanded steadily into a full-service global CRO, acquired real-world data analytics firm Symphony Health in 2017, and was ultimately acquired by ICON plc in 2021 in a transaction valued at approximately $12 billion.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating